This assay is intended for the in vitro quantitative measurement of human immunodeficiencyvirus type 1 (HIV-1) RNA in human plasma using Real-Time PCR technology. It is used to monitor the effectiveness of antiretroviral therapy and may serve as a supplemental aid in the diagnosis of HIV infection. This assay is not intended for donor screening or as a confirmatory diagnostic tool for HIV-1 infection.
Lyophilised Reagent
China's first ready‑to‑use solution with zero waste
Quant by Internal Control
No additional reagent consumption required, with traceability to international standards
Dual‑Target Genes
LTR + pol dual targets reduce the risk of false‑negative results.
Reliable Storage & Logistics
2‑8°C storage and transportation, stable at room temperature for ≥1 week
| Product | Molvizon HIV‑1 |
| Quantitative method | Internal standard quantification |
| Linear range | 30‑1.0 × 10⁸ IU/mL copies/mL |
| LoQ | 30 IU/mL (17.6 copies/mL) |
| Specimen Volume | 0.5 mL Plasma |
| Detection Target | LTR and pol genes |
| Subtype coverage | HIV‑1 Group M, O and N |
| Storage Conditions | 2‑8°C, protected from light |
| Shelf Life | 24 months |
| Packaging Specifications | 48 tests/kit, 96 tests/kit |
Cat. No. | Product Name | Spec. | Certificate |
M1011 | Molvizon HIV-1 | 48 Tests/Kit | NMPA |